MARKET CLOSE: NZ shares fall as Ebos shareholder sells down; covid jitters remain

MARKET CLOSE: NZ shares fall as Ebos shareholder sells down; covid jitters remain
Dan Brunskill
New Zealand shares fell as a cornerstone investor of Ebos Group sold down a 9 percent stake in the healthcare products company, dominating trading today. Investors also remain concerned about the threat of a second wave of covid-19. The S&P/NZX 50 Index fell 25.88 points, or 0.2 percent, to 11,132.58. Within the index, 33 stocks fell, 12 rose, and five were unchanged. Turnover was $800.5 million, of which Ebos accounted for $629.2 million.  Ebos fell 3.2 percent to $21.63 after its biggest shareholder sold 9.2 percent of the company for $...

More Markets

Ebos targets cost base
Markets

Ebos targets cost base

Animal and health care firm says it will manage costs and keep hunting for acquisitions.

NZME reports 46% full-year profit drop
Markets

NZME reports 46% full-year profit drop

NZME's 2023 net profit was $12.2 million versus $22.7m in 2022. 

Synlait's bankers will 'extend and pretend'
Primary Sector

Synlait's bankers will 'extend and pretend'

Company owes $130m to be repaid in five weeks and it hasn't sold its cheese brand yet.

Comvita slips into loss in half-year results
Markets

Comvita slips into loss in half-year results

The mānuka honey company hopes for a rebound in its Chinese market.